BRPI0307074A2 - meios sem soro para condrócitos e métodos para seu uso - Google Patents

meios sem soro para condrócitos e métodos para seu uso

Info

Publication number
BRPI0307074A2
BRPI0307074A2 BRPI0307074A BRPI0307074A BRPI0307074A2 BR PI0307074 A2 BRPI0307074 A2 BR PI0307074A2 BR PI0307074 A BRPI0307074 A BR PI0307074A BR PI0307074 A BRPI0307074 A BR PI0307074A BR PI0307074 A2 BRPI0307074 A2 BR PI0307074A2
Authority
BR
Brazil
Prior art keywords
methods
serum free
chondrocyte media
media
free chondrocyte
Prior art date
Application number
BRPI0307074A
Other languages
English (en)
Inventor
Maria E Brown Liesbeth
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BRPI0307074A2 publication Critical patent/BRPI0307074A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655Chondrocytes; Cartilage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/135Platelet-derived growth factor [PDGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/58Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0307074A 2002-01-25 2003-01-24 meios sem soro para condrócitos e métodos para seu uso BRPI0307074A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35194902P 2002-01-25 2002-01-25
US38907802P 2002-06-14 2002-06-14
PCT/US2003/001941 WO2003064598A2 (en) 2002-01-25 2003-01-24 Serum-free media for chondrocytes and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0307074A2 true BRPI0307074A2 (pt) 2017-06-20

Family

ID=27669045

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307074A BRPI0307074A2 (pt) 2002-01-25 2003-01-24 meios sem soro para condrócitos e métodos para seu uso

Country Status (7)

Country Link
US (2) US7169610B2 (pt)
EP (1) EP1478734A4 (pt)
JP (1) JP2005515777A (pt)
AU (1) AU2008264154A1 (pt)
BR (1) BRPI0307074A2 (pt)
CA (1) CA2473360A1 (pt)
WO (1) WO2003064598A2 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2552229C (en) 2003-12-26 2013-03-12 Miho Furue Basal medium for es cell culturing
US8889127B2 (en) 2004-07-01 2014-11-18 Icahn School Of Medicine At Mount Sinai Targeted protein replacement for the treatment of lysosomal storage disorders
CN101014699B (zh) * 2004-08-24 2010-05-26 富士软件株式会社 去分化型软骨细胞向软骨细胞的再分化用培养基
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20090169523A1 (en) 2005-06-13 2009-07-02 Catherine Verfaillie Hsc self-renewal
EP1945809B1 (en) * 2005-08-16 2012-06-27 The Children's Mercy Hospital Quantification of microsphere suspension hybridization and uses thereof
EP1930413B1 (en) * 2005-08-23 2011-01-12 Oriental Yeast Co., Ltd. Technique for culture of mesenchymal stem cell utilizing laminin-5
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP1764117A1 (en) 2005-09-20 2007-03-21 Zimmer GmbH Implant for the repair of a cartilage defect and method for manufacturing the implant
JP4385076B2 (ja) 2006-01-13 2009-12-16 独立行政法人科学技術振興機構 動物細胞を無血清培養するための培地用添加剤、キット及びこれらの利用
BRPI0713572A2 (pt) * 2006-06-20 2012-10-23 Stephen Duguay meios livres de soro e seus usos para expansão de condrócitos
MX2009010694A (es) * 2007-04-06 2009-10-22 Genzyme Corp Metodo para evaluar celulas y cultivos celulares.
KR101574989B1 (ko) * 2007-12-28 2015-12-21 후지레비오 가부시키가이샤 포유 동물 체세포용 배지 및 이를 위한 첨가제
WO2009092092A1 (en) 2008-01-18 2009-07-23 Regents Of The University Of Minnesota Stem cell aggregates and methods for making and using
KR20170073614A (ko) * 2008-03-21 2017-06-28 티슈진, 인코포레이티드 추간디스크 퇴행 치료용 조성물
WO2010055616A1 (ja) * 2008-11-11 2010-05-20 独立行政法人科学技術振興機構 分化誘導培地用添加剤およびその利用
US11248211B2 (en) * 2008-11-25 2022-02-15 Kolon Tissuegene, Inc. Primed cell therapy
US20110020292A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of Stem Cells to Reduce Leukocyte Extravasation
EP2456853B1 (en) 2009-07-21 2020-10-28 ABT Holding Company Use of stem cells to reduce leukocyte extravasation
CA2791331A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of angiogenesis
SG183497A1 (en) 2010-02-25 2012-09-27 Abt Holding Co Modulation of macrophage activation
JP5804385B2 (ja) 2010-03-10 2015-11-04 株式会社ツーセル 間葉系幹細胞を含む細胞製剤及びその製造方法
DK2568991T6 (en) 2010-05-12 2019-03-18 Abt Holding Co MODULATION OF SPLENOCYTES IN CELL THERAPY
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
SG10201914007YA (en) 2010-08-24 2020-03-30 Univ Minnesota Non-static suspension culture of cell aggregates
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US9388388B2 (en) 2011-01-31 2016-07-12 Katholieke Universiteit Leuven Methods for making cells with an extra-embryonic endodermal precursor phenotype
US9562252B2 (en) * 2011-05-13 2017-02-07 Biogen Ma Inc. Methods of preventing and removing trisulfide bonds
WO2012168295A1 (en) 2011-06-06 2012-12-13 ReGenesys BVBA Expansion of stem cells in hollow fiber bioreactors
WO2013019857A2 (en) 2011-08-01 2013-02-07 Alnylam Pharmaceuticals, Inc. Method for improving the success rate of hematopoietic stem cell transplants
EP3741384A1 (en) 2011-09-07 2020-11-25 Mount Sinai School Of Medicine Ceramidase and cell differentiation
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
SG11201402108YA (en) 2011-11-11 2014-06-27 Essential Pharmaceuticals Llc Kit comprising serum replacement and labile factors
CN109529028A (zh) 2012-06-01 2019-03-29 西奈山伊坎医学院 在感染的治疗和预防中的神经酰胺水平
EP2875125B1 (en) 2012-07-20 2018-10-24 Alfred C. Kuo Methods for producing cartilage and bone
WO2014160390A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Therapeutic acid ceramidase compositions and methods of making and using them
PT2983680T (pt) 2013-04-12 2020-10-29 Abt Holding Co Melhoria de órgãos para transplante
ES2753323T3 (es) 2013-04-30 2020-04-08 Univ Leuven Kath Terapia celular para síndromes mielodisplásicos
CA3135208A1 (en) * 2013-06-11 2014-12-18 Ncardia B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells
EP3009503B1 (en) * 2013-06-12 2019-08-07 Shiseido Company Ltd. Serum-free medium containing pdgf for ds cells
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
SG11201604994UA (en) 2013-12-20 2016-07-28 Essential Pharmaceuticals Llc Media for cell culture
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
JP6780638B2 (ja) * 2015-03-30 2020-11-04 味の素株式会社 ヒト血清アルブミンを含む神経幹細胞増殖培地
US10967006B2 (en) 2016-01-21 2021-04-06 Abt Holding Company Stem cells for wound healing
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
SG11202003354VA (en) 2017-10-13 2020-05-28 Boehringer Ingelheim Int Perfusion medium
US11857576B2 (en) * 2017-12-07 2024-01-02 Vericel Corporation Compositions and methods for repairing cartilage defects
CN109136170B (zh) * 2018-08-20 2022-02-18 东北农业大学 一种适用于鲤鱼三倍体细胞生长的无血清培养基及其应用
WO2020176801A1 (en) 2019-02-28 2020-09-03 Fagg William Samuel Iv Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing
CN113061578B (zh) * 2021-04-23 2023-04-21 苏州依科赛生物科技股份有限公司 一种用于细胞培养基的脂质混合物及其配制方法与应用
US12226438B2 (en) * 2021-06-18 2025-02-18 Hilltop BioSciences, Inc. System and method for therapeutic compositions from a plurality of different birth tissues and exosomes
JP2025507959A (ja) 2022-03-04 2025-03-21 ヴェリセル コーポレイション 軟骨の欠損を修復するための方法及びデバイス
JPWO2025018336A1 (pt) * 2023-07-20 2025-01-23
WO2025037108A2 (en) 2023-08-15 2025-02-20 Board Of Trustees Of The Leland Stanford Junior University Modified thrombopoietin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904717A (en) * 1986-01-28 1999-05-18 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5723331A (en) * 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ,インコーポレイテッド 造血細胞培養栄養補充成分
EP0920490A2 (en) * 1996-07-25 1999-06-09 Genzyme Corporation Chondrocyte media formulations and culture procedures
US6001352A (en) * 1997-03-31 1999-12-14 Osteobiologics, Inc. Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
WO1998059035A2 (en) * 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
JP2002529071A (ja) 1998-11-09 2002-09-10 コンソルツィオ・ペール・ラ・ジェスティオーネ・デル・チェントロ・ディ・ビオテクノロジー・アヴァンツァテ 軟骨細胞様細胞のための無血清培地
US6429013B1 (en) * 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
FR2798671A1 (fr) 1999-09-16 2001-03-23 Univ Paris Curie Compositions de chondrocytes, preparation et utilisations
WO2001057083A1 (en) 2000-02-04 2001-08-09 Zymogenetics, Inc. Methods for promoting growth of bone, ligament, and cartilage using zvegf4
US20020041900A1 (en) * 2000-05-01 2002-04-11 Ole Olsen Chondrocyte cultures and fractions therefrom

Also Published As

Publication number Publication date
US20030211604A1 (en) 2003-11-13
WO2003064598A3 (en) 2003-10-16
EP1478734A2 (en) 2004-11-24
JP2005515777A (ja) 2005-06-02
US20070275463A1 (en) 2007-11-29
EP1478734A4 (en) 2006-04-05
US7169610B2 (en) 2007-01-30
CA2473360A1 (en) 2003-08-07
WO2003064598A2 (en) 2003-08-07
AU2008264154A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
NO20023713D0 (no) 2-benzotiazolyl-urea-derivater samt anvendelse derav som proteinkinaseinhibitorer
ATE435859T1 (de) Gyraseinhibitoren und deren verwendungen
NO20043564L (no) Follistatindomene som inneholder proteiner
PT1107920E (pt) Embalagem tubular apresentando uma manga exterior e uma bolsa interna para armazenamento
EP1649381A4 (en) SYSTEMS AND METHODS FOR MANAGING PROJECTS
AU2003206399A8 (en) Methods and systems for managing business representative distributions
AU2003256605A1 (en) Integrated toilet and air deodorizer
ITMI20010138V0 (it) Compact disc di forma circolare e non circolare
ES1052324Y (es) Protector absorbente para respaldos y superficies.
ES1052880Y (es) Pasarela para zanjas y similares.
ES1054563Y (es) "soporte para bebidas y similares"
ES1052701Y (es) Soporte para bolsos y similares
ES1052298Y (es) Soporte para cubiteras y similares.
ES1052162Y (es) Contenedor para ostricultura y similares.
ES1055092Y (es) Mecanismo para sillas de oficina y similares
ES1051634Y (es) Envase expositor desplegable para botellas y similares.
ES1054205Y (es) Soporte indicador para restauracion y hosteleria.
ES1053112Y (es) Expositor para estuches de dvd y similares.
ES1051295Y (es) Silo para aridos y similares.
ES1049996Y (es) Dispositivo para la sustentacion y retencion de piezas de gran formato en superficies verticales.
ES1046629Y (es) Expositor perfeccionado para celosias y balaustres.
ES1053815Y (es) Soporte para fotografias y similares.
ES1055498Y (es) Panel comercial para exposicion y almacenamiento.
ES1053085Y (es) Conjunto de lavabo y mueble para cuartos de baño.
ES1056201Y (es) Espadin perfeccionado para la distribucion y consumo de aperitivos.

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]